Saturn V Capital Management »

Zura Bio shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 740k 5.95

More positions owned by Saturn V Capital Management

Alumis (ALMS)
Amylyx Pharmaceuticals (AMLX)
Abivax Sa Sponsored Ads (ABVX)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Immix Biopharma (IMMX)
Celcuity (CELC)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Disc Medicine (IRON)
X4 Pharmaceuticals Com New (XFOR)
Cogent Biosciences (COGT)
Monopar Therapeutics Com New (MNPR)
Dyne Therapeutics (DYN)
Adagio Therapeutics (IVVD)
Candel Therapeutics (CADL)

View all positions for Saturn V Capital Management

Top funds holding Zura Bio

Suvretta Capital Management
VR Adviser
Dr. Jeffrey R. Jay, M.D.
Braidwell
Siren
Commodore Capital
Pfizer
Adage Capital Partners GP
Affinity Asset Advisors
Millennium Management
Armistice Capital
Cormorant Asset Management
QVT Financial
Ikarian Capital
EcoR1 Capital

View all funds holding Zura Bio